RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.

Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.

Add to Collection
2016 Dec Others Fist_Author_Year_PM

Full Author : ['Espinoza, Sara E', 'Wang, Chen-Pin', 'Tripathy, Devjit', 'Clement, Stephen C', 'Schwenke, Dawn C', 'Banerji, Mary Ann', 'Bray, George A', 'Buchanan, Thomas A', 'Henry, Robert R', 'Kitabchi, Abbas E', 'Mudaliar, Sunder', 'Stentz, Frankie B', 'Reaven, Peter D', 'DeFronzo, Ralph A', 'Musi, Nicolas']
Journal Title : Age (Dordrecht, Netherlands)
Chapter : Section3
Journal Year : 2016
Cited by : Not Available

To determine the efficacy of pioglitazone to prevent type 2 diabetes in older compared to younger adults with pre-diabetes. Six hundred two participants with impaired glucose tolerance (IGT) were randomized in double blind fashion to placebo or pioglitazo.....

Keywords : ["old versus young adult", "impair glucose tolerance", "equally effective", "diabetes prevention", "pioglitazone"]